نتائج البحث - Ross, David M

Need to minimize bias when surveying patient attitudes to stopping cml treatment حسب Villemagne–Sanchez, Lucia A., Ross, David M., Schofield, Penelope

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Persistence of myelofibrosis treated with ruxolitinib: biology and clinical implications حسب Ross, David M., Babon, Jeffrey J., Tvorogov, Denis, Thomas, Daniel

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: Two case reports with maternal and fetal outcomes and literature review حسب Chua, Su J, Morton, Mark R, Svigos, John, Ross, David M, Kane, Simon

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features حسب Ross, David M., Bartley, Paul A., Goyne, Jarrad, Morley, Alexander A., Seymour, John F., Grigg, Andrew P.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study حسب Ho, P. Joy, Hiwase, Devendra, Ramakrishna, Raj, Viiala, Nicholas, Solterbeck, Ann, Traficante, Robert, Zor, Evren, Gervasio, Othon L., High, Laura M., Ross, David M., Bowden, Donald K.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Predicting chemotherapy‐induced menopause using baseline and post‐chemotherapy anti‐Müllerian hormone levels: Results of a pilot study حسب Martin, Hilary Laura, Ullah, Shahid, Abbas, Nazim, Scott‐Hoy, Alex, Kichenadasse, Ganessan, Karapetis, Christos Stelios, Roy, Amitesh, Sukumaran, Shawgi, Ross, David M, Khattak, Muhammad Adnan, Koczwara, Bogda

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia حسب Pagani, Ilaria S., Dang, Phuong, Kommers, Ivar O., Goyne, Jarrad M., Nicola, Mario, Saunders, Verity A., Braley, Jodi, White, Deborah L., Yeung, David T., Branford, Susan, Hughes, Timothy P., Ross, David M.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody حسب Tvorogov, Denis, Thompson‐Peach, Chloe A L, Foßelteder, Johannes, Dottore, Mara, Stomski, Frank, Onnesha, Suraiya A, Lim, Kelly, Moretti, Paul A B, Pitson, Stuart M, Ross, David M, Reinisch, Andreas, Thomas, Daniel, Lopez, Angel F

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study حسب Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, Al-Ali, Haifa Kathrin

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study حسب Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, Al-Ali, Haifa Kathrin

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosis حسب Tvorogov, Denis, Thomas, Daniel, Liau, Nicholas P. D., Dottore, Mara, Barry, Emma F., Lathi, Maya, Kan, Winnie L., Hercus, Timothy R., Stomski, Frank, Hughes, Timothy P., Tergaonkar, Vinay, Parker, Michael W., Ross, David M., Majeti, Ravindra, Babon, Jeffrey J., Lopez, Angel F.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study حسب Mascarenhas, John, Passamonti, Francesco, Burbury, Kate, El-Galaly, Tarec Christoffer, Gerds, Aaron, Gupta, Vikas, Higgins, Brian, Wonde, Kathrin, Jamois, Candice, Kovic, Bruno, Huw, Ling-Yuh, Katakam, Sudhakar, Maffioli, Margherita, Mesa, Ruben, Palmer, Jeanne, Bellini, Marta, Ross, David M., Vannucchi, Alessandro M., Yacoub, Abdulraheem

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome حسب Singhal, Deepak, Kutyna, Monika M., Chhetri, Rakchha, Wee, Li Yan A., Hague, Sophia, Nath, Lakshmi, Nath, Shriram V., Sinha, Romi, Wickham, Nicholas, Lewis, Ian D., Ross, David M., Bardy, Peter G., To, Luen Bik, Reynolds, John, Wood, Erica M., Roxby, David J., Hiwase, Devendra K.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial حسب Radich, Jerald P., Hochhaus, Andreas, Masszi, Tamás, Hellmann, Andrzej, Stentoft, Jesper, Casares, María Teresa Gómez, García-Gutiérrez, J. Valentín, Conneally, Eibhlin, le Coutre, Philipp D., Gattermann, Norbert, Martino, Bruno, Saussele, Susanne, Giles, Francis J., Ross, David M., Aimone, Paola, Li, Sai, Titorenko, Ksenia, Saglio, Giuseppe

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib حسب Cheah, Chan Y., Burbury, Kate, Apperley, Jane F., Huguet, Francoise, Pitini, Vincenzo, Gardembas, Martine, Ross, David M., Forrest, Donna, Genet, Philippe, Rousselot, Philippe, Patton, Nigel, Smith, Graeme, Dunbar, Cynthia E., Ito, Sawa, Aguiar, Ricardo C. T., Odenike, Olatoyosi, Gimelfarb, Alla, Cross, Nicholas C. P., Seymour, John F.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study حسب Ross, David M., Masszi, Tamas, Gómez Casares, María Teresa, Hellmann, Andrzej, Stentoft, Jesper, Conneally, Eibhlin, Garcia-Gutierrez, Valentin, Gattermann, Norbert, le Coutre, Philipp D., Martino, Bruno, Saussele, Susanne, Giles, Francis J., Radich, Jerald P., Saglio, Giuseppe, Deng, Weiping, Krunic, Nancy, Bédoucha, Véronique, Gopalakrishna, Prashanth, Hochhaus, Andreas

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets حسب Yeung, David T., Osborn, Michael P., White, Deborah L., Branford, Susan, Braley, Jodi, Herschtal, Alan, Kornhauser, Michael, Issa, Samar, Hiwase, Devendra K., Hertzberg, Mark, Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K., Kwan, Yiu Lam, Trotman, Judith, Forsyth, Cecily J., Taper, John, Ross, David M., Beresford, Jennifer, Tam, Constantine, Mills, Anthony K., Grigg, Andrew P., Hughes, Timothy P.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia حسب Bassal, Mahmoud A., Samaraweera, Saumya E., Lim, Kelly, Benard, Brooks A., Bailey, Sheree, Kaur, Satinder, Leo, Paul, Toubia, John, Thompson-Peach, Chloe, Nguyen, Tran, Maung, Kyaw Ze Ya, Casolari, Debora A., Iarossi, Diana G., Pagani, Ilaria S., Powell, Jason, Pitson, Stuart, Natera, Siria, Roessner, Ute, Lewis, Ian D., Brown, Anna L., Tenen, Daniel G., Robinson, Nirmal, Ross, David M., Majeti, Ravindra, Gonda, Thomas J., Thomas, Daniel, D’Andrea, Richard J.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia حسب Bassal, Mahmoud A., Samaraweera, Saumya E., Lim, Kelly, Benard, Brooks A., Bailey, Sheree, Kaur, Satinder, Leo, Paul, Toubia, John, Thompson-Peach, Chloe, Nguyen, Tran, Maung, Kyaw Ze Ya, Casolari, Debora A., Iarossi, Diana G., Pagani, Ilaria S., Powell, Jason, Pitson, Stuart, Natera, Siria, Roessner, Ute, Lewis, Ian D., Brown, Anna L., Tenen, Daniel G., Robinson, Nirmal, Ross, David M., Majeti, Ravindra, Gonda, Thomas J., Thomas, Daniel, D’Andrea, Richard J.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

COVID‐19 vaccination in haematology patients: an Australian and New Zealand consensus position statement حسب McCaughan, Georgia, Di Ciaccio, Pietro, Ananda‐Rajah, Michelle, Gilroy, Nicole, MacIntyre, Raina, Teh, Benjamin, Weinkove, Robert, Curnow, Jennifer, Szer, Jeff, Enjeti, Anoop K, Ross, David M, Mulligan, Stephen, Trotman, Judith, Dickinson, Michael, Quach, Hang, Choi, Phillip, Polizzotto, Mark N., Tam, Constantine S., Ho, P. Joy, Ku, Matthew, Gregory, Gareth, Gangatharan, Shane, Hapgood, Greg, Cochrane, Tara, Cheah, Chan, Gibbs, Simon, Wei, Andrew, Johnston, Anna, Greenwood, Matthew, Prince, H. Miles, Latimer, Maya, Berkahn, Leanne, Wight, Joel, Armytage, Tasman, Hamad, Nada

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل